Xiamen Kingdomway Group Co. Stock Analysis 002626.SZ

Xiamen Kingdomway Group Co. engages in the production and sales of raw materials for food nutrient enhancers and health food end products. The company is headquartered in Xiamen, Fujian and currently employs 2,184 full-time employees. The company went IPO on 2011-10-28. The firm's raw materials include coenzyme Q10, Docosahexaenoic Acid (DHA), Arachidonic Acid (ARA), vitamin A, vitamin D3, vitamin K2, nattokinase, pyrroloquinoline quinone (PQQ), Nicotinamide Mononucleotide (NMN), astaxanthin, inositol series products and others. The feed additives produced by the Company include vitamin A, vitamin D3 and others. The firm also produces pharmaceutical raw materials such as praziquantel, alanylglutamine, and oxiracetam. The firm mainly operates its businesses in the domestic and overseas markets.